220 related articles for article (PubMed ID: 30070379)
1. Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.
Singal AG; Tiro JA; Murphy CC; Marrero JA; McCallister K; Fullington H; Mejias C; Waljee AK; Pechero Bishop W; Santini NO; Halm EA
Hepatology; 2019 Jan; 69(1):121-130. PubMed ID: 30070379
[TBL] [Abstract][Full Text] [Related]
2. Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.
Singal AG; Tiro JA; Marrero JA; McCallister K; Mejias C; Adamson B; Bishop WP; Santini NO; Halm EA
Gastroenterology; 2017 Feb; 152(3):608-615.e4. PubMed ID: 27825963
[TBL] [Abstract][Full Text] [Related]
3. Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.
Singal AG; Reddy S; Radadiya Aka Patel H; Villarreal D; Khan A; Liu Y; Cerda V; Rich NE; Murphy CC; Tiro JA; Kramer JR; Hernaez R
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2818-2825.e1. PubMed ID: 34902568
[TBL] [Abstract][Full Text] [Related]
4. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
6. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
[TBL] [Abstract][Full Text] [Related]
8. Current Practice of Hepatocellular Carcinoma Surveillance.
Loho IM; Siregar L; Waspodo AS; Hasan I
Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
[TBL] [Abstract][Full Text] [Related]
9. [Screening of hepatocellular carcinoma and surveillance of patients with cirrhosis: a public health issue].
Trinchet JC; Nahon P; Ganne-Carrie N
Rev Prat; 2013 Feb; 63(2):222-5. PubMed ID: 23513790
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG
Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684
[TBL] [Abstract][Full Text] [Related]
11. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.
Atiq O; Tiro J; Yopp AC; Muffler A; Marrero JA; Parikh ND; Murphy C; McCallister K; Singal AG
Hepatology; 2017 Apr; 65(4):1196-1205. PubMed ID: 27775821
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
[No Abstract] [Full Text] [Related]
13. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
Tzartzeva K; Obi J; Rich NE; Parikh ND; Marrero JA; Yopp A; Waljee AK; Singal AG
Gastroenterology; 2018 May; 154(6):1706-1718.e1. PubMed ID: 29425931
[TBL] [Abstract][Full Text] [Related]
14. Quality improvement measures lead to higher surveillance rates for hepatocellular carcinoma in patients with cirrhosis.
Aberra FB; Essenmacher M; Fisher N; Volk ML
Dig Dis Sci; 2013 Apr; 58(4):1157-60. PubMed ID: 23111632
[TBL] [Abstract][Full Text] [Related]
15. Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis.
Singal AG; Chen Y; Sridhar S; Mittal V; Fullington H; Shaik M; Waljee AK; Tiro J
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1795-1802.e2. PubMed ID: 33662594
[TBL] [Abstract][Full Text] [Related]
16. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ
Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044
[TBL] [Abstract][Full Text] [Related]
18. Surveillance for hepatocellular carcinoma: how can we do better?
Hassett M; Yopp AC; Singal AG
Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
[TBL] [Abstract][Full Text] [Related]
19. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]